Amgen to invest over $200M in India tech facility

Drugmaker Amgen to invest $200 million in India site, CEO says
U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, CEO Robert Bradway said at the inauguration of the site on Monday.
Amgen to invest over $200M in India tech facility: report
Amgen (NASDAQ:AMGN) reportedly plans to invest over $200M in its newly opened technology and innovation center in Hyderabad, India. The site, which was officially opened on Monday, is expected to employ around 2,
Amgen plans $200M investment in India site, Reuters reports
Amgen (AMGN) plans to invest about $200M this year in its new technology center in southern India, with further investments planned, Reuters’
Amgen to invest $200 million in India
US drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, CEO Robert
Amgen Invests $200M in India Tech Hub to Boost AI-Driven Drug Development
Amgen (NASDAQ: AMGN) is investing $200 million in its new technology and innovation center in Hyderabad, India, to enhance AI and data-driven drug development. CEO Robert Bradway, speaking at the sites inauguration,
Amgen opens new tech and innovation centre in Hyderabad with starting investment of $200m in 2025
HYDERABAD: US-based biopharma giant on Monday opened its new technology and innovation centre in Hyderabad with its CEO Robert Bradway announcing a $200 million investment commitment in the facility through 2025 with additional investments planned in future years.
Amgen to invest $200 million in India site, CEO says
U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further investments planned, Chief Executive Officer Robert Bradway said at the inauguration of the site on Monday.
Amgen shares snapped six straight sessions of gains
Amgen (NASDAQ:AMGN) shares snapped six straight sessions of gains, as the stock ended 3% lower at $306.2 on Wednesday. The ...
At conference, drugmakers tout AI efforts as US tariffs cast shadow
The rising adoption of artificial intelligence in the pharmaceutical industry dominated discussions at a conference in India ...